Page last updated: 2024-10-27

fluorouracil and Carcinoma, Signet Ring Cell

fluorouracil has been researched along with Carcinoma, Signet Ring Cell in 103 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.

Research Excerpts

ExcerptRelevanceReference
"Based upon preclinical data showing synergy with mTOR inhibition and platinum chemotherapy, this study explores the safety and tolerability of combining everolimus with mFOLFOX6 for patients with metastatic gastroesophageal adenocarcinoma."9.22Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma. ( Chao, J; Chung, S; Chung, V; Fakih, MG; Frankel, P; Koehler, S; Lau, SC; Leong, L; Lim, D; Luevanos, E; Ruel, N; Yeon, C, 2016)
"We report a case in which weekly paclitaxel (TXL) administration was effective for gastric cancer with malignant ascites."7.71[Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report]. ( Ezaki, T; Ikegami, T; Ishida, T; Itoh, H; Kawaguchi, K; Kido, A; Nose, N; Sasaki, Y; Shimokawa, H, 2002)
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases."5.39Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013)
"Based upon preclinical data showing synergy with mTOR inhibition and platinum chemotherapy, this study explores the safety and tolerability of combining everolimus with mFOLFOX6 for patients with metastatic gastroesophageal adenocarcinoma."5.22Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma. ( Chao, J; Chung, S; Chung, V; Fakih, MG; Frankel, P; Koehler, S; Lau, SC; Leong, L; Lim, D; Luevanos, E; Ruel, N; Yeon, C, 2016)
"The aim of this study was to determine whether the relative mRNA expressions of the thymidylate synthase (TYMS) and the excision repair cross-complementing 1 (ERCC1) genes are associated with in vitro chemosensitivity to 5-fluorouracil (5-FU) and oxaliplatin in colorectal cancer, respectively."3.77Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. ( Cho, YB; Choi, SH; Chun, HK; Chung, HJ; Kim, HC; Lee, WY; Yun, SH, 2011)
"We describe our experience with a patient who had undifferentiated gastric carcinoma with extensive lymph node metastasis, including para-aortic lymph-node metastasis, and had a complete response to induction therapy with methotrexate plus 5-fluorouracil (sequential therapy with MTX, 5-FU, and Leucovorin) and secondary treatment with oral TS-1."3.73[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1]. ( Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M, 2005)
"We report a case in which weekly paclitaxel (TXL) administration was effective for gastric cancer with malignant ascites."3.71[Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report]. ( Ezaki, T; Ikegami, T; Ishida, T; Itoh, H; Kawaguchi, K; Kido, A; Nose, N; Sasaki, Y; Shimokawa, H, 2002)
"We consider that our observations in gastric cancer patients in our clinic can be useful in the future randomised trials to point the way to improved outcomes."2.79Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution. ( Coskun-Breuneval, M; Demirkasimoglu, T; Elgin, Y; Guney, Y; Kara, SP; Kucukpilakci, B; Misirlioglu, HC; Ozgen, A; Sanri, E; Ugur, VI, 2014)
"Gastric cancer is the second most common among cancer-related deaths in the world."2.77Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution. ( Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M, 2012)
"This oxaliplatin combined with ELF regimen shows good efficacy and acceptable safety in advanced gastric cancer patients."2.74[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer]. ( Lou, F; Pan, HM; Zhu, YH, 2009)
"Of the 96 patients with gastric cancers, 21 underwent R0 resection and afterward received adjuvant FOLFOX chemotherapy."2.74[FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer]. ( Dai, H; Yan, D, 2009)
" This study was to investigate the efficacy and safety of oxaliplatin in combination with capecitabine as first-line chemotherapy for AGC patients."2.74[Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer]. ( Dong, NN; Liu, ZF; Wang, MY; Zhang, Q, 2009)
"We hypothesised that gastric cancer outcome could be improved with more effective and intensified postoperative chemoradiotherapy."2.73Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. ( Bartelink, H; Boot, H; Cats, A; Dubbelman, R; Jansen, EP; Verheij, M, 2007)
"5-fluorouracil (5-FU) has been widely used for the treatment of gastrointestinal cancers."2.69[Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers]. ( Horimi, T; Morita, S; Shirasaka, T; Takahashi, I; Takasaki, M; Tsuji, A, 1999)
"From a global perspective, gastric cancer including cancer of the esophago-gastric junction is the fourth most common malignant tumor and the second-most common cause of cancer-related death."2.46[Diagnosis and treatment of gastric cancer]. ( Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G, 2010)
"Patients with PM from colorectal cancer and PCI >20 that were treated with CRS and HIPEC experience a one year longer and doubled overall survival compared with open-close/debulking patients."1.56Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. ( Artursson, S; Birgisson, H; Cashin, P; Enblad, M; Ghanipour, L; Graf, W, 2020)
"Metastatic and refractory gastric cancer (GC) are associated with a poor prognosis; therefore, the identification of prognostic factors and chemosensitivity markers is extremely important."1.43Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. ( Altan, B; Asao, T; Bai, T; Bao, P; Hara, K; Ide, M; Kimura, A; Kogure, N; Kuwano, H; Mochiki, E; Nishiyama, M; Ogata, K; Oyama, T; Suzuki, M; Toyomasu, Y; Yokobori, T, 2016)
"A total of 196 stage II and III colon cancer patients were retrospectively enrolled in prospectively collected data."1.42T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. ( An, MS; Bae, KB; Choi, CS; Hong, KH; Hwang, JW; Kang, MS; Kim, BM; Kim, JH; Kim, KH; Oh, MK; Yoo, JH, 2015)
"Signet ring cell gastric cancer (SRCGC) has very poor prognosis worldwide, and studying its molecular characteristics is urgent for improving the outcome."1.42Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. ( Cao, J; Feng, JG; Gu, LH; He, KF; Jin, KT; Li, GL; Qian, LJ; Su, XY; Teng, LS; Wang, HH; Xu, X; Xu, ZZ; Zhang, J; Zhou, Q, 2015)
"The study included 405 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection and received adjuvant therapy between January 2008 and July 2009."1.40Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. ( Bae, JM; Choi, MG; Kang, WK; Kim, S; Lee, J; Lee, JH; Lee, SJ; Lim, DH; Lim, HY; Park, JO; Park, SH; Park, YS; Sohn, TS, 2014)
"Capecitabine (CA) is an orally administered fluoropyrimidine carbamate which is preferentially converted to active 5-FU and is one of the agents used instead of FU in such cases."1.39Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? ( Isikli, L; Yoney, A, 2013)
"Colorectal carcinoma is rare in the paediatric population but is increasing in incidence."1.38Metastatic paediatric colorectal carcinoma. ( Kennedy, MJ; Larkin, JO; McCormick, P; Mehigan, B; Muldoon, C; Woods, R, 2012)
"A total of 31 patients with advanced gastric cancer was included."1.38The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer. ( Bilici, A; Ercan, S; Gumus, M; Orcun, A; Seker, M; Ustaalioglu, BB; Yilmaz, BE, 2012)
"The majority of patients with gastric cancer in developing countries present with advanced disease."1.38Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. ( Guven, M; Inal, A; Işikdogan, A; Kaplan, MA; Kuçukoner, M; Nas, N; Urakci, Z; Yunce, M, 2012)
"We studied 26 gastric cancer patients with lymph node metastasis who underwent gastric resection at the Korea University Guro Hospital from Feb 2007 to July 2008."1.37Metastatic lymph node targeted chemosensitivity test for gastric cancer. ( Jang, YJ; Kim, CS; Kim, JH; Kim, SJ; Mok, YJ; Park, SH; Park, SS, 2011)
"The gastric cancer was complicated by malignant pericardial effusion and pleural effusion as well as metastasis to the peripheral lymph nodes and bones."1.36A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy. ( Qin, YW; Xu, RL; Zhang, BL; Zheng, X, 2010)
"We hypothesized that the sensitivity of gastric cancer to 5-FU treatment might be related to the rate of glucose transport (GLUT), and investigated the expressions of GLUT1, 2, 3, and 4 in two different gastric cancer cells (SNU-216, moderately differentiated gastric adenocarcinoma; and SNU-668, signet ring cell gastric carcinoma)."1.36Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells. ( Baik, HH; Cho, HY; Ha, E; Ha, TK; Hur, SJ; Kim, YH; Kwon, SJ; Suh, SI; Won, HJ, 2010)
"104 patients with advanced gastric cancers were treated with capecitabine-based chemotherapy regimens from Sept."1.35[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. ( Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD, 2009)
"Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours."1.34[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007)
"In vitro, human colon cancer cell lines were treated with anti-CEA MAb IgG1, hMN-14 (labetuzumab), to assess direct effects on proliferation, as well as antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC)."1.33Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft. ( Blumenthal, RD; Goldenberg, DM; Hansen, HJ; Hayes, MK; Horak, ID; Osorio, L, 2005)
" Furthermore, she was administered tegafur/uracil (400 mg/day) 5 days weekly for pharmacokinetic modulating chemotherapy (PMC)."1.33[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005)
"Case 1 A 40-year-old female with gastric cancer located in the MULE area underwent total gastrectomy with D3 lymph node dissection on June 2, 1989."1.32[Two patients with metastatic ovarian tumor (Krukenberg's tumor) of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection]. ( Arai, K; Horiguchi, S; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Nishioka, K; Takahashi, K; Yamaguchi, T, 2003)
"Six patients with gastric cancer, stage IIIA to IV, received intraabdominal cisplatin (CDDP) at laporotomy."1.31[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion]. ( Kagawa, R; Nakayama, N; Sakata, S; Tada, M; Yamaguchi, T, 2002)
"Final diagnosis stated a multilocular metastasising gastric cancer with infiltration of bone, peritoneum and dura and signet-cell infiltration of the bone marrow."1.31[Hemorrhagic diathesis as initial symptom of stomach carcinoma]. ( Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH, 2000)
"Nocturnal infusion of 5-fluorouracil (5-FU) combined with pamidronate was performed in a 62-year-old male gastric cancer patient with multiple bone metastasis."1.30[A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate]. ( Fukano, S; Furuya, Y; Kinugasa, T; Kohno, N; Maekawa, Y; Sekimoto, K; Toyokawa, A, 1998)
"The role in colorectal cancer is less clear, although there are some reports that suggest a benefit."1.30Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer. ( Clingan, P; Horsell, KW; King, DW; Merten, S; Morris, DL, 1999)
"Three cases of postoperative gastric cancer with peritoneal dissemination were treated by combined administration of CDDP, 5-FU and Lentinan."1.29[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan]. ( Mio, H; Terabe, K, 1994)
"A 41-year-old woman diagnosed as gastric cancer with peritoneal dissemination was admitted for operation."1.29[A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil]. ( Fukuda, I; Kishimoto, S; Kokufu, I; Miyake, Y, 1995)

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's19 (18.45)18.2507
2000's31 (30.10)29.6817
2010's48 (46.60)24.3611
2020's5 (4.85)2.80

Authors

AuthorsStudies
Otta-Oshiro, RJ1
Lista-Mateos, F1
Encinas-García, S1
Morales-García, S1
Núñez-Mora, C1
Nakajima, Y1
Kajiwara, A1
Sakaki, M1
Otoyama, Y1
Nishihara, S1
Suzuki, N1
Usami, T1
Nakatani, S1
Wang, T1
Yoshida, H1
Lin, YL1
Zhang, J3
Yan, FC1
Jiang, X1
Ma, R1
Yang, ZR1
Xu, HB1
Peng, Z1
Chen, Q1
Li, Y3
Kolla, BC1
Petersen, A1
Chengappa, M1
Gummadi, T1
Ganesan, C1
Gaertner, WB1
Blaes, A1
Henry, M1
Delavari, N1
Webber, J1
Birgisson, H1
Enblad, M1
Artursson, S1
Ghanipour, L1
Cashin, P1
Graf, W1
Kosmala, R1
Fokas, E1
Flentje, M1
Sauer, R2
Liersch, T2
Graeven, U1
Fietkau, R2
Hohenberger, W2
Arnold, D1
Hofheinz, RD1
Ghadimi, M1
Ströbel, P1
Staib, L1
Grabenbauer, GG1
Folprecht, G1
Kirste, S1
Uter, W1
Gall, C1
Rödel, C2
Polat, B1
Goense, L1
van Rossum, PSN1
Xi, M1
Maru, DM1
Carter, BW1
Meijer, GJ1
Ho, L1
van Hillegersberg, R1
Hofstetter, WL1
Lin, SH1
Rombouts, AJM1
Hugen, N1
Verhoeven, RHA1
Elferink, MAG1
Poortmans, PMP1
Nagtegaal, ID1
de Wilt, JHW1
Jiang, ZC1
Chi, Y1
Huelster, HL1
Hogan, MMS1
Resnick, MJ1
Wang, L2
Li, PF1
Geng, M2
Cao, YC2
Yin, YC2
Piessen, G1
Messager, M1
Le Malicot, K1
Robb, WB1
Di Fiore, F1
Guilbert, M1
Moreau, M1
Christophe, V1
Adenis, A1
Mariette, C1
Yoney, A1
Isikli, L1
Toiyama, Y1
Inoue, Y1
Saigusa, S1
Kawamura, M1
Kawamoto, A1
Okugawa, Y1
Hiro, J1
Tanaka, K1
Mohri, Y1
Kusunoki, M1
Wu, H1
He, YL1
Xu, JB1
Cai, SR1
Ma, JP1
Chen, CQ1
Zhang, XH1
Zhan, WH1
Kasliwal, MK1
Tan, LA1
O'Toole, JE1
Kaytan Saglam, E1
Yucel, S1
Balik, E1
Saglam, S1
Asoglu, O1
Yamaner, S1
Bugra, D1
Oral, EN1
Kizir, A1
Kapran, Y1
Sakar, B1
Akyuz, A1
Gulluoglu, M1
Lee, SJ1
Sohn, TS1
Lee, J2
Park, SH2
Park, JO2
Lim, DH1
Park, YS2
Lim, HY2
Choi, MG1
Lee, JH1
Bae, JM1
Kim, S1
Kang, WK2
Misirlioglu, HC1
Coskun-Breuneval, M1
Kucukpilakci, B1
Ugur, VI1
Elgin, Y1
Demirkasimoglu, T1
Kara, SP1
Ozgen, A1
Sanri, E1
Guney, Y1
Choe, JH1
Overman, MJ1
Fournier, KF1
Royal, RE1
Ohinata, A1
Rafeeq, S1
Beaty, K1
Phillips, JK1
Wolff, RA1
Mansfield, PF1
Eng, C1
Milovanov, V1
Sardi, A1
Ledakis, P1
Aydin, N1
Nieroda, C1
Sittig, M1
Nunez, M1
Gushchin, V1
An, MS1
Yoo, JH1
Kim, KH1
Bae, KB1
Choi, CS1
Hwang, JW1
Kim, JH3
Kim, BM1
Kang, MS1
Oh, MK1
Hong, KH1
Xu, X1
Qian, LJ1
Su, XY1
He, KF1
Jin, KT1
Gu, LH1
Feng, JG1
Li, GL1
Zhou, Q1
Xu, ZZ1
Wang, HH1
Cao, J1
Teng, LS1
Altan, B1
Yokobori, T1
Ide, M1
Mochiki, E1
Toyomasu, Y1
Kogure, N1
Kimura, A1
Hara, K1
Bai, T1
Bao, P1
Suzuki, M2
Ogata, K1
Asao, T1
Nishiyama, M1
Oyama, T1
Kuwano, H1
Chung, V1
Frankel, P1
Lim, D1
Yeon, C1
Leong, L1
Chao, J1
Ruel, N1
Luevanos, E1
Koehler, S1
Chung, S1
Lau, SC1
Fakih, MG1
Mizoshita, T1
Kataoka, H1
Kubota, E1
Okamoto, Y1
Shimura, T1
Mori, Y1
Wada, T1
Ogasawara, N1
Sasaki, M1
Kamiya, T1
Joh, T1
Xavier, MH1
Vergueiro, Tde R1
Vilar, EG1
Pinto, JM1
Issa, MC1
Pereira, GB1
Carocha, AP1
Jain, AK1
Motil, KJ1
Olutoye, OO1
Cope-Yokoyama, S1
Egler, RA1
Tatevian, N1
Lou, F1
Zhu, YH1
Pan, HM1
Yan, D1
Dai, H1
Xiao, Y1
Lu, M1
Li, J1
Zhang, XD1
Shen, L1
Dong, NN1
Wang, MY1
Zhang, Q1
Liu, ZF1
Qiu, MZ1
Teng, KY1
Ruan, DY1
Li, YH1
Chen, XQ1
Pan, ZZ1
He, YJ1
Wan, DS1
Xu, RH1
Jansen, EPM1
Boot, H2
Dubbelman, R2
Verheij, M2
Cats, A2
Kadikoylu, G1
Barutca, S1
Tataroglu, C1
Kafkas, S1
Erpek, H1
Meydan, N1
Yavasoglu, I1
Bolaman, Z1
Won, HJ1
Ha, TK1
Kwon, SJ1
Cho, HY1
Hur, SJ1
Baik, HH1
Suh, SI1
Ha, E1
Kim, YH1
Yoshitani, S1
Hosokawa, K1
Yokoi, M1
Kinami, S1
Omote, K1
Ueda, N1
Nakano, Y1
Kosaka, T1
Mastoraki, A1
Papanikolaou, IS1
Kanakis, D1
Safioleas, P1
Sakorafas, G1
Safioleas, M1
Kanagavel, D1
Pokataev, IA1
Fedyanin, MY1
Tryakin, AA1
Bazin, IS1
Narimanov, MN1
Yakovleva, ES1
Garin, AM1
Tjulandin, SA1
Sato, S1
Mukai, M1
Aneiros-Fernandez, J1
Husein-ElAhmed, H1
Arias-Santiago, S1
Escobar Gómez-Villalva, F1
Nicolae, A1
O'Valle Ravassa, F1
Aneiros-Cachaza, J1
Zhang, BL1
Xu, RL1
Zheng, X1
Qin, YW1
Lordick, F1
Grenacher, L1
Röcken, C1
Ebert, M1
Moehler, M1
Schumacher, G1
Jang, YJ1
Park, SS1
Kim, SJ1
Kim, CS1
Mok, YJ1
Eich, HT1
Stepien, A1
Zimmermann, C1
Hellmich, M1
Metzger, R1
Hölscher, A1
Müller, RP1
Karabay, CY1
Gecmen, C1
Aung, SM1
Guler, A1
Candan, O1
Batgerel, U1
Kalayci, A1
Kirma, C1
Takai, H1
Kondoh, E1
Sato, Y1
Kakui, K1
Tatsumi, K1
Konishi, I1
Wang, F1
Wang, Z2
Zhou, N1
An, X1
Xu, R1
He, Y1
Ioannidis, O1
Papaemmanouil, S1
Paraskevas, G1
Chatzopoulos, S1
Kotronis, A1
Papadimitriou, N1
Makrantonakis, A1
Kakoutis, E1
Cho, YB1
Chung, HJ1
Lee, WY1
Choi, SH1
Kim, HC1
Yun, SH1
Chun, HK1
Inal, A2
Kaplan, MA2
Kucukoner, M2
Isikdogan, A2
Roldán, AM1
Núñez, NF1
Grande, E1
García, AÁ1
Antón-Aparicio, LM1
Ferrand, FR1
Gontier, E1
Guymar, S1
Fagot, T1
Ceccaldi, B1
Malfuson, JV1
de Revel, T1
Chen, YG1
Kao, WY1
Tsai, SH1
Woods, R1
Larkin, JO1
Muldoon, C1
Kennedy, MJ1
Mehigan, B1
McCormick, P1
Vigliar, E1
Marino, G1
Matano, E2
Imbimbo, C1
Rossella, de C1
Insabato, L1
Bilici, A1
Ustaalioglu, BB1
Ercan, S1
Seker, M1
Yilmaz, BE1
Orcun, A1
Gumus, M1
Urakci, Z1
Guven, M1
Nas, N1
Yunce, M1
Hur, H1
Xuan, Y1
Kim, YB1
Lee, G1
Shim, W1
Yun, J1
Ham, IH1
Han, SU1
Liang, JW1
Zhou, ZX1
Zhang, XM1
Hu, JJ1
Zhao, P1
Kang, EJ1
Im, SA1
Oh, DY1
Han, SW1
Kim, JS1
Choi, IS1
Kim, JW1
Kim, YJ1
Kim, TY1
Lee, JS1
Bang, YJ1
Lee, KW1
Ishida, T1
Shimokawa, H1
Kawaguchi, K1
Nose, N1
Ikegami, T1
Itoh, H1
Kido, A1
Sasaki, Y1
Ezaki, T1
Kagawa, R1
Nakayama, N1
Yamaguchi, T3
Sakata, S1
Tada, M1
Segura Huerta, A1
Pérez-Fidalgo, JA1
López-Tendero, P1
Gironés Sarrió, R1
Aparicio Urtasun, J1
Nabeshima, S1
Kishihara, Y1
Nabeshima, A1
Yamaga, S1
Kinjo, M1
Kashiwagi, S1
Hayashi, J1
Nishioka, K1
Arai, K2
Iwasaki, Y2
Katayanagi, S1
Takahashi, K1
Matsumoto, H1
Miyamoto, H1
Horiguchi, S1
Leitman, M1
Baram, S1
Sidenko, S1
Abo-Kishk, I1
Peleg, E1
Vered, Z1
Harting, MT1
Blakely, ML1
Herzog, CE1
Lally, KP1
Ajani, JA1
Andrassy, RJ1
Blumenthal, RD1
Osorio, L1
Hayes, MK1
Horak, ID1
Hansen, HJ1
Goldenberg, DM1
Ishikawa, T1
Mizuno, K1
Togashi, T1
Watanabe, K1
Seki, K1
Ohta, H1
Yoshida, T1
Kamimura, T1
De Vita, F1
Orditura, M1
Bianco, R1
Carlomagno, C1
Infusino, S1
Damiano, V1
Simeone, E1
Diadema, MR1
Lieto, E1
Castellano, P1
Pepe, S1
De Placido, S1
Galizia, G1
Di Martino, N1
Ciardiello, F1
Catalano, G1
Bianco, AR1
Hiramatsu, K1
Mizukami, Y1
Momiyama, M1
Niimi, K1
Nagashima, T1
Martus, P1
Papadoupolos, T1
Füzesi, L1
Klimpfinger, M1
Raab, R1
Wittekind, C1
Kwon, JM1
Oh, SY1
Lee, HR1
Kim, HJ1
Park, BB1
Han, MJ1
Resnik, KS1
DiLeonardo, M1
Gibbons, G1
Jansen, EP1
Bartelink, H1
Mitsuno, M1
Kitajima, Y1
Ide, T1
Ohtaka, K1
Tanaka, M1
Satoh, S1
Miyazaki, K1
Mohile, SG1
Schleicher, L1
Petrylak, DP1
Fu, ZJ1
Wang, XY1
Tai, YH1
Bellman, B1
Gregory, NA1
Silvers, D1
Fountain, KS1
Bondar', GV1
Zabudkin, AF1
Bukhteev, SV1
Aizawa, K1
Muto, I1
Suzuki, S1
Tanaka, N1
Yabusaki, H2
Tanaka, S1
Katayanagi, N1
Suzuki, T1
Tanaka, O2
Muto, T1
Mio, H1
Terabe, K1
Fujishima, H1
Mitsugi, K1
Nakamura, M1
Yoshimatsu, H1
Nakano, S1
Niho, Y1
Murase, M1
Kondo, K1
Kodera, Y1
Kiriyama, K1
Akiyama, S1
Ito, K1
Yokoyama, Y1
Shirasaka, T2
Takagi, H1
Miyazaki, N1
Ohkura, H1
Kajimura, N1
Okazaki, N1
Kokufu, I1
Fukuda, I1
Miyake, Y1
Kishimoto, S1
Kitamura, M1
Kostandy, G1
Katapadi, M1
Pullarkat, V1
Manzi, G1
Salama, S1
Sosler, B1
Hussain, KM1
Noda, N1
Sano, T2
Shirao, K1
Ono, H1
Katai, H2
Sasako, M2
Maruyama, K2
Deeb, LS1
Yamout, BI1
Shamseddine, AI1
Shabb, NS1
Uthman, SM1
Muguruma, K1
Nakata, B1
Hirakawa, K1
Yamashita, Y1
Onoda, N1
Inoue, T1
Matsuoka, T1
Kato, Y1
Sowa, M1
Kuniyasu, T1
Nakamura, T1
Tabuchi, Y1
Kuroda, Y1
Maekawa, Y1
Furuya, Y1
Toyokawa, A1
Kinugasa, T1
Fukano, S1
Sekimoto, K1
Kohno, N1
Tsuji, A1
Morita, S1
Horimi, T1
Takasaki, M1
Takahashi, I1
Hosoya, Y1
Kitoh, Y1
Kobayashi, E1
Okabe, R1
Fujimura, A1
Kanazawa, K1
Horsell, KW1
Merten, S1
Clingan, P1
King, DW1
Morris, DL1
Tanabe, T1
Nashimoto, A1
Sasaki, J1
Sano, M1
Tsutsui, M1
Tsuchiya, Y1
Makino, H1
Akiyama, N1
Ohta, T1
Yang, TS1
Hsu, KC1
Tang, R1
Chang, TC1
Dempke, W1
von Poblozki, A1
Kellner, O1
Wolf, HH1
Schmoll, HJ1
Heidemann, J1
Gockel, HR1
Winde, G1
Herbst, H1
Domschke, W1
Lügering, N1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rect[NCT00349076]Phase 31,256 participants (Actual)Interventional2006-07-31Completed
Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)[NCT01717924]314 participants (Anticipated)Interventional2012-10-31Recruiting
A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study)[NCT00407186]Phase 3788 participants (Actual)Interventional2007-01-11Active, not recruiting
Randomized Phase 3 Study of Xelox(Capecitabine Plus Oxaliplatin) Followed by Maintenance Capecitabine or Observation in Patients With Advanced Gastric Adenocarcinoma[NCT02289547]Phase 3184 participants (Anticipated)Interventional2015-05-31Recruiting
Total Neoadjuvant Therapy in Rectal Cancer Treatment[NCT04747951]Phase 4280 participants (Anticipated)Interventional2020-10-30Recruiting
Randomized Phase 2 Study Comparing Pathological Responses on Colorectal Cancer Metastases After Preoperative Treatment Combining Bevacizumab With FOLFOX or FOLFIRI[NCT01858649]Phase 260 participants (Actual)Interventional2013-05-31Completed
Randomised Phase 2 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors[NCT01858662]Phase 24 participants (Actual)Interventional2014-01-31Terminated (stopped due to due to poor recrutment)
Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.[NCT03034473]200 participants (Actual)Interventional2011-08-31Active, not recruiting
Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy[NCT00855946]46 participants (Actual)Observational2009-05-31Completed
KCSP Trial of cONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After neoadjUvant Concurrent chemoraDiothErapy: A Multicenter, Randomized Controlled Trial (KONCLUDE Trial)[NCT02843191]Phase 3358 participants (Anticipated)Interventional2016-12-31Recruiting
Evaluation of an Alternative Schedule for CRLX101 Alone in Combination With Bevacizumab and in Combination With mFOLFOX6 in Subjects With Advanced Solid Tumor Malignancies[NCT02648711]Phase 141 participants (Actual)Interventional2015-10-31Terminated (stopped due to Company decision)
Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449]Phase 3338 participants (Actual)Interventional2012-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for fluorouracil and Carcinoma, Signet Ring Cell

ArticleYear
Undiagnosed Case of Signet Ring Cell Colorectal Carcinoma: A Case Report and Review of the Literature.
    Clinical colorectal cancer, 2020, Volume: 19, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant;

2020
[Diagnosis and treatment of gastric cancer].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:34-35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endo

2010
Signet-ring-cell carcinoma of stomach metastatic to the bladder: a case report with cytological and histological correlation and literature review.
    International journal of surgical pathology, 2013, Volume: 21, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cytodiagnosis; F

2013
Meningeal carcinomatosis as the presenting manifestation of gastric adenocarcinoma.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:2

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Car

1997

Trials

19 trials available for fluorouracil and Carcinoma, Signet Ring Cell

ArticleYear
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
    European journal of cancer (Oxford, England : 1990), 2021, Volume: 144

    Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri

2021
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.
    BMC cancer, 2013, Jun-10, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant;

2013
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2015
Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:20

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2014
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma.
    Oncology, 2016, Volume: 90, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

2016
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro

2009
[FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

2009
[Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2009
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma

2010
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring

2010
Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
    American journal of clinical oncology, 2011, Volume: 34, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Female; Fl

2011
Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution.
    Neoplasma, 2012, Volume: 59, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2012
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
    British journal of cancer, 2005, May-09, Volume: 92, Issue:9

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; D

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinom

2005
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2007
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2007
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2007
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2007
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
    British journal of cancer, 2007, Sep-17, Volume: 97, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P

2007
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.
    Journal of gastroenterology, 2007, Volume: 42, Issue:11

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cel

2007
[Arterial infusion chemotherapy for advanced gastric cancer by sequential MTX/5-FU].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Ad

1996
[Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

1999

Other Studies

80 other studies available for fluorouracil and Carcinoma, Signet Ring Cell

ArticleYear
Metachronous Signet Ring Cell Bladder Metastasis as First Sing of Cancer Recurrence.
    Urology, 2019, Volume: 134

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adj

2019
[Primary appendiceal signet ring cell carcinoma:a case report].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2019, Volume: 116, Issue:11

    Topics: Appendiceal Neoplasms; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Female; Fluorouracil; Huma

2019
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.
    Cancer medicine, 2020, Volume: 9, Issue:3

    Topics: Animals; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Humans; Injections, Intraperitoneal; Mal

2020
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
    Cancer medicine, 2020, Volume: 9, Issue:10

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2020
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:12

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Intravenous; Adolescent; Adult; Aged; Aged

2020
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
    Annals of surgical oncology, 2018, Volume: 25, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Che

2018
Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2018, Volume: 44, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Carcinoma, Signet Ring

2018
[Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2018, Aug-23, Volume: 40, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2018
Acute Renal Transplant Failure Secondary to an Obstructing Ileal Conduit Adenocarcinoma: Case Report and Literature Review.
    Urology, 2019, Volume: 134

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Disease Progress

2019
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
    Diagnostic pathology, 2013, Feb-22, Volume: 8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke

2013
Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma?
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine

2013
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Anticancer research, 2013, Volume: 33, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto

2013
[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cel

2013
Intradural tumor recurrence after resection of extradural metastasis: a rare but potential complication of intraoperative durotomy.
    Journal of neurosurgery. Spine, 2014, Volume: 20, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; C

2014
Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Anticancer research, 2014, Volume: 34, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

2014
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
    Annals of surgical oncology, 2015, Volume: 22, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N

2015
Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA).
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:5

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Ch

2015
T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    World journal of surgical oncology, 2015, Feb-19, Volume: 13

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carci

2015
Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line.
    International journal of oncology, 2015, Volume: 46, Issue:6

    Topics: Animals; Carcinoma, Signet Ring Cell; Cell Line, Tumor; Cell Proliferation; China; Drug Resistance,

2015
Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Apoptosis; Biomarke

2016
Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil.
    International journal of clinical oncology, 2008, Volume: 13, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Female;

2008
Cutaneous metastasis of gastric adenocarcinoma: an exuberant and unusual clinical presentation.
    Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cachexia; Carcinoma, Signet Ring Cell; Etoposide; Fl

2008
Colon cancer in a 16-year-old girl: signet-ring cell carcinoma without microsatellite instability--an unusual suspect.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Colonic Neo

2009
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2009
[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Antineoplastic Combined Chemothe

2009
Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2010, Volume: 42, Issue:1

    Topics: Abdomen, Acute; Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bio

2010
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
    Anti-cancer drugs, 2010, Volume: 21, Issue:3

    Topics: Antimetabolites, Antineoplastic; Biological Transport; Carcinoma, Signet Ring Cell; Cell Line, Tumor

2010
[A case of anal canal carcinoma with systemic lymph node metastases successfully treated by bevacizumab+mFOLFOX6 therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Anal Canal; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti

2009
A case of signet ring carcinoma of the appendix: dilemmas in differential diagnosis and management.
    Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:2

    Topics: Abdominal Pain; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Appendiceal Neoplasms;

2010
Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer.
    Diagnostic pathology, 2010, Feb-24, Volume: 5

    Topics: Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Signet Ring Cell; Cell Differentiation; Chemothe

2010
Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma.
    Dermatology online journal, 2010, Mar-15, Volume: 16, Issue:3

    Topics: Aged; Antineoplastic Agents; Capecitabine; Carcinoma, Signet Ring Cell; Deoxycytidine; Docetaxel; Fl

2010
A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy.
    Medical science monitor : international medical journal of experimental and clinical research, 2010, Volume: 16, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cardiac Tamponade; Drug

2010
Metastatic lymph node targeted chemosensitivity test for gastric cancer.
    The Journal of surgical research, 2011, Volume: 171, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; An

2011
Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2011, Volume: 187, Issue:4

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcin

2011
Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge.
    Perfusion, 2011, Volume: 26, Issue:6

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Coronary Vasospasm; Electrocardiograph

2011
Disseminated intravascular coagulation as the presenting sign of gastric cancer during pregnancy.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Signet Ring

2011
Primary Signet Ring Cell Anal Adenocarcinoma.
    Journal of gastrointestinal cancer, 2012, Volume: 43 Suppl 1

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Signet Ring Cell; Col

2012
Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.
    Anticancer research, 2011, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carc

2011
A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.
    Clinical genitourinary cancer, 2012, Volume: 10, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap

2012
Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.
    Onkologie, 2012, Volume: 35, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma; Carcinoma, Signet

2012
Nonspecific but significant.
    The American journal of medicine, 2012, Volume: 125, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Signet Ring Cell; Colonic Neop

2012
Metastatic paediatric colorectal carcinoma.
    Irish medical journal, 2012, Volume: 105, Issue:3

    Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevac

2012
The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carc

2012
Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasm

2012
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
    International journal of oncology, 2013, Volume: 42, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Blotting, Western;

2013
[Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol

2012
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013, Volume: 16, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brid

2013
[Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinom

2002
[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:11

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin

2002
[Thirteen years' survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that?].
    Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Cobalt Radio

2003
Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2003, Volume: 94, Issue:7

    Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma,

2003
[Two patients with metastatic ovarian tumor (Krukenberg's tumor) of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:11

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Carcinom

2003
Transient left ventricular and right atrial thrombosis after 5-fluorouracil therapy.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2004, Volume: 17, Issue:7

    Topics: Abdominal Neoplasms; Adolescent; Carcinoma, Signet Ring Cell; Echocardiography; Fluorouracil; Heart

2004
Treatment issues in pediatric gastric adenocarcinoma.
    Journal of pediatric surgery, 2004, Volume: 39, Issue:8

    Topics: Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Sig

2004
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft.
    Cancer immunology, immunotherapy : CII, 2005, Volume: 54, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemo

2005
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4

    Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ri

2005
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:8

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr

2005
Clinically occult cutaneous metastases.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon

2006
Treatment of metastatic urachal carcinoma in an elderly woman.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Com

2008
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:11

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim

2007
Sweat gland carcinoma with metastases to the skin: response to 5-fluorouracil chemotherapy.
    Cutis, 1995, Volume: 55, Issue:4

    Topics: Aged; Bone Marrow Diseases; Bone Neoplasms; Carcinoma, Signet Ring Cell; Facial Neoplasms; Fluoroura

1995
[The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
    Klinicheskaia khirurgiia, 1994, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

1994
Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.
    Surgery today, 1994, Volume: 24, Issue:5

    Topics: Carcinoma, Signet Ring Cell; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Dr

1994
[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cel

1994
[A case of advanced gastric cancer complicated with multiple liver metastasis successfully treated with l-LV and 5-FU combination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administrati

1994
[The clinical effect of chemotherapy with 5-FU and low-dose CDDP in patients with advanced gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

1994
Semiautomated 14C-thymidine incorporation assay for in vitro screening of anticancer drug.
    Human cell, 1993, Volume: 6, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Signet Ring Cell; Cell Divis

1993
[A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:14

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Femal

1995
Skin metastases: an unusual presenting sign of gastric carcinoma.
    Journal of clinical gastroenterology, 1996, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Doxorubicin; Female; Fl

1996
A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval.
    Japanese journal of clinical oncology, 1996, Volume: 26, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell;

1996
[p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25 Suppl 3

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Apo

1998
Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.
    Cancer, 1998, Oct-01, Volume: 83, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies; Antimetabolites, Antineoplastic; Carcino

1998
[A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Diphosp

1998
Combination effects of tamoxifen plus 5-fluorouracil on gastric cancer cell lines in vitro.
    Cancer letters, 1999, Jun-01, Volume: 140, Issue:1-2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cell Di

1999
Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer.
    The Australian and New Zealand journal of surgery, 1999, Volume: 69, Issue:10

    Topics: Abscess; Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic;

1999
[A case of advanced gastric cancer with abdominal para-aortic lymph node metastasis successfully treated with FLP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:13

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Carcinoma, S

1999
Colon carcinoma with synchronous ovarian metastasis--report and discussion of five cases.
    Anti-cancer drugs, 2000, Volume: 11, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring

2000
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
    Wiener klinische Wochenschrift, 2000, Dec-22, Volume: 112, Issue:24

    Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplasti

2000
Node-positive mucosal gastric cancer: a follow-up study.
    Japanese journal of clinical oncology, 2001, Volume: 31, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Female; Fluorourac

2001
Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:1

    Topics: Abdominal Neoplasms; Aged; Back; Biopsy, Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differentia

2002
chemdatabank.com